Discovery Laboratories, Inc. (Nasdaq:DSCO - News) today announced that it is offering to sell shares of its common stock in an underwritten public offering.
The Company also expects to grant the underwriters a 30-day option to purchase additional shares of common stock to cover over-allotments, if any. Lazard Capital Markets LLC is acting as the sole book-running manager for the offering, Stifel Nicolaus Weisel is acting as co-lead manager, and ROTH Capital Partners, LLC is acting as co-manager. While the offering is expected to price before 9:30 am EDT on March 16, 2012, the offering is subject to market conditions, and there can be no assurance as to whether or when the offering may be completed, or as to the actual size or terms of the offering.
